Indaptus Therapeutics, Inc.

NASDAQ:INDP

Biotechnology

Healthcare
$3.29 -2.21%

-$0.03 today

Market cap
$372.57M
Beta
1.14
P/E (TTM)
-0.2
EPS (TTM)
-$8.70
52W Low $0.92High $8.69

Volume 0.17M

Average 0.97M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$14.82M

FY 2025 · Annual

Investing Cash Flow

$0.00

FY 2025 · Annual

Financing Cash Flow

$17.54M

FY 2025 · Annual

+269.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
Depreciation & Amortization1.4K1.78K1.28K7350
Deferred Income Tax(5.75M)0000
Stock-Based Compensation1.51M2.96M2.97M2.31M1.36M
Change in Working Capital(5.09M)(1.58M)(518.07K)392.26K3.51M
Accounts Receivables00000
Inventory00000
Accounts Payables(4.24M)(1.15M)(680.52K)474.06K2.85M
Other Working Capital(854.15K)(425.59K)162.45K(81.8K)665.3K
Other Non-Cash Items5.75M(134.16K)(430.99K)01.15M
Operating Cash Flow(11.29M)(13.08M)(13.41M)(12.32M)(14.82M)
Capital Expenditures(3.85K)(172.56K)00(4)
Acquisitions (Net)451.6K172.56K000
Purchases of Investments0(29.6M)(6.86M)00
Sales of Investments013M24M00
Other Investing Activities0172.56K000
Investing Cash Flow447.75K(16.43M)17.14M00
Debt Repayment00005.71M
Common Stock Issued5M005.51M11.83M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities43.34M00(762.7K)0
Financing Cash Flow48.34M004.75M17.54M
Effect of Forex Changes00000
Net Change in Cash37.49M(29.51M)3.74M(7.58M)2.72M
Free Cash Flow(11.29M)(13.25M)(13.41M)(12.32M)(14.82M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$20.8M
+ D&A$0
+ Stock-Based Comp$1.4M
+ Deferred Tax$0
+ Working Capital$3.5M
+ Other Non-Cash$1.2M
= Operating Cash Flow-$14.8M
- Capex-$4
= Free Cash Flow-$14.8M

Analysis

FY2025 free cash flow is -$14.8M. FCF conversion is 71.1% of net income. Operating cash flow was -$14.8M, with capex of -$4. The largest bridge item is Working Capital at $3.5M.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13D/ASC 13D/A filingOct 22, 2026
SC 13D/ASC 13D/A filingOct 22, 2026
SC 13D/ASC 13D/A filingOct 22, 2026

Does INDP generate free cash flow?

Indaptus Therapeutics, Inc. (INDP) generated -$14.82M of free cash flow in fiscal 2025.

How much operating cash flow does INDP produce?

Operating cash flow was -$14.82M, before capital expenditures of $4.00.